Results
|
3441.
|
Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma. [electronic resource] by
- Ueshima, Kazuomi
- Kudo, Masatoshi
- Takita, Masahiro
- Nagai, Tomoyuki
- Tatsumi, Chie
- Ueda, Taisuke
- Kitai, Satoshi
- Ishikawa, Emi
- Yada, Norihisa
- Inoue, Tatsuo
- Hagiwara, Satoru
- Minami, Yasunori
- Chung, Hobyung
- Sakurai, Toshiharu
Producer: 20111227
In:
Digestive diseases (Basel, Switzerland) vol. 29
Availability: No items available.
|
|
3442.
|
|
|
3443.
|
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma. [electronic resource] by
- Cabrera, R
- Pannu, D S
- Caridi, J
- Firpi, R J
- Soldevila-Pico, C
- Morelli, G
- Clark, V
- Suman, A
- George, T J
- Nelson, D R
Producer: 20111207
In:
Alimentary pharmacology & therapeutics vol. 34
Availability: No items available.
|
|
3444.
|
|
|
3445.
|
|
|
3446.
|
|
|
3447.
|
|
|
3448.
|
|
|
3449.
|
|
|
3450.
|
|
|
3451.
|
|
|
3452.
|
|
|
3453.
|
|
|
3454.
|
|
|
3455.
|
|
|
3456.
|
|
|
3457.
|
|
|
3458.
|
|
|
3459.
|
|
|
3460.
|
|